Publications by authors named "Floryane Kim"

Claim this Profile
E
Erratum to 'Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review' [Journal of Thoracic Oncology Volume 19 Issue 7 (2024) 973-983].
Maxime Borgeaud, Kaushal Parikh, Giuseppe Luigi Banna, Floryane Kim, Timothée Olivier

J Thorac Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Trametinib in the treatment of patients with metastatic lung adenocarcinoma harboring mutation: a case series and literature review.
Floryane Kim, Maxime Borgeaud, Claudio De Vito, Petros Tsantoulis, Alfredo Addeo

Front Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin for colorectal cancer chemoprevention: where are we?
Vassilis Genoud, Floryane Kim, Thibaud Koessler

Curr Opin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary and Acquired Resistance to Immunotherapy with Checkpoint Inhibitors in NSCLC: From Bedside to Bench and Back.
Annapaola Mariniello, Maxime Borgeaud, Marc Weiner, Daniele Frisone, Floryane Kim

BioDrugs· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review.
Maxime Borgeaud, Kaushal Parikh, Giuseppe Luigi Banna, Floryane Kim, Timothée Olivier

J Thorac Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of stage III non-small-cell lung cancer: rays of hope.
Floryane Kim, Maxime Borgeaud, Alfredo Addeo, Alex Friedlaender

Explor Target Antitumor Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleural Mesothelioma in the Era of Immunotherapy.
Mathieu Chevallier, Floryane Kim, Alex Friedlaender, Alfredo Addeo

Clin Med Insights Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma.
Maxime Borgeaud, Floryane Kim, Alex Friedlaender, Filippo Lococo, Alfredo Addeo

J Clin Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis